hotspot -WSS

hotspot

author：fashion 2025-08-31 16:41:01 - browse：5

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — European regulators on Friday reiterated their view that an ALS treatment from Amylyx Pharmaceuticals should not be approved, likely dooming the drug’s chances for now.

A European Medicines Agency committee had initially recommended against approving the drug, known as Albrioza, in June. Friday’s confirmation of that position came after the company appealed the decision. While the European Commission officially decides whether to approve a new medicine, it almost always follows the committee’s guidance. The final decision is expected to be made before the end of the year.

The drug, which won approval last year in the United States and is marketed Relyvrio, is designed to slow the progression of the fatal neurological condition. In its pivotal trial, patients who received the drug over 24 weeks scored about two points better on a 48-point scale of symptoms than those who got a placebo, indicating the drug slowed disease progression.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Listen: Vivek Ramaswamy's star turn & leaky drug data

entertainment

WSS

Republicans love RFK Jr. What's that tell us about health in 2024?

FDA greenlights medical device to combat bladder issues

After a drawn out lobbying fight, ARPA

Did you have Obamacare on your GOP debate bingo card?

California store owner shot dead in dispute over displaying Pride flag: Police

How to make over

entertainment

hotspot

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Paxlovid should be available without a positive Covid test

Guidelines to prevent youth baseball injuries need more muscle

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Supreme Court strikes down use of affirmative action

Shingles, which affected Dianne Feinstein, is on the rise

Heart attack and stroke risk calculators need revising

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

In Memoriam: Notable people who died in 2023

Inequities make cancer less preventable for women: report

hotspot

FDA advisory panel to debate high blood pressure devices

Data show record exodus of life scientists from academia

People can get long Covid without testing positive for virus: Study

Kellogg’s is going to war over Mexico’s nutrition label rules

Kaiser Permanente unions announce official strike date

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

entertainment

explore

leisure time

knowledge